The company's initial target is immuno-oncology projects but there are plans to expand into autoimmune disease, infectious disease, and more.

The annual application window typically opens in early November but will be “delayed indefinitely until the Trump Administration and Washington Republicans act to end the government shutdown and fund ...

AllOne Health Unveils Landmark Work/Life Study: Profile of 59,137 Real-World Cases Shows Wide Range of Everyday Needs Drive EAP Use—Legal, Financial, Life Assistance, and Personal Health. EAP is not ...

The annual application window typically opens in early November but will be “delayed indefinitely until the Trump Administration and Washington Republicans act to end the government shutdown and fund ...

Just as organizations have developed sophisticated approaches to supporting new parents, similar strategic thinking can ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced its financial results for the fiscal ...

CEO Sujal Patel highlighted meaningful progress across the scientific platform and operational priorities, emphasizing, "Q3 was another important quarter for Nautilus. We made meaningful progress ...

Without additional state dollars, thousands of La. children could lose access to affordable child care by 2030, a report by ...

Smart Assist: An AI companion and digital gateway into Smartsheet that helps users accelerate time-to-value by creating workspaces and projects from simple outlines, activating automations and ...

TELUS Digital Philippines’ commitment to employee well-being is part of a broader strategy that combines inclusive culture, ...